Company / AR per Share
GeneDx Holdings Corp. AR per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$2.65
FY2025
5-year range
$1.45 / $213782.26
FY2021-FY2025
Trend
+83.3%
vs FY2024
Sector context
#80 of 141
Health Care
What the data says
At $2.65, GeneDx Holdings Corp.'s ar per share ranks #80 of 141 in the Health Care sector. AR per Share returned to growth in FY2025 after 2 years of decline, reaching $2.65.
Based on SEC 10-K filings.
2.65 in FY2025 with a 5-year CAGR of -78.8%.
Declined from $8309.10 to $2.65 over the past 3 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -93.2%
- 5-Year CAGR
- -78.8%
- 10-Year CAGR
- -
Sector benchmark
#80 of 141 in Health CareTop 57% of 141This company $2.65 Sector average $11.78
▼
-77.5% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 83.3% year-over-year.
- Ranks #80 out of 141 companies in the Health Care sector.
- Peak ar per share was recorded in FY2021.
- Lowest ar per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.65 | +83.3% |
| FY2024 | $1.45 | - |
| FY2023 | - | - |
| FY2022 | $8309.10 | -96.1% |
| FY2021 | $213782.26 | +3323.2% |
| FY2020 | $6245.18 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026